Ondine Biomedical Inc. (OBI.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 75.12M |
| Enterprise Value | 64.95M |
| P/E Ratio | -4.32 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 45.77 |
| Price/Book Ratio | 38.69 |
| Enterprise/Revenue | 41.95 |
| Enterprise/EBITDA | -3.77 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -11.17 |
| Operating Margin | -11.34 |
AD
Management Effectiveness
| Return On Assets | -2.07 |
| Return On Equity | -14.12 |
Income Statement
| Revenue | 2.65M |
| Revenue/Share | 0.01 |
| Gross Profit | 1.09M |
| EBITDA | -29.45M |
| Net Income | -29.59M |
| Diluted EPS | -0.06 |
Balance Sheet
| Total Cash | 10.58M |
| Total Cash/Share | 0.02 |
| Total Debt | 413,496 |
| Total Debt/Equity | 0.12 |
| Current Ratio | 1.23 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | 1.72 |
| 52-Week High | 18.5 |
| 52-Week Low | 7.5 |
| Moving Average 50 Days | 13.49 |
| Moving Average 200 Days | 11.6 |
Statistics
| Average Volume | 504,153 |
| Shares Outstanding | 441M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
